Vanguard Capital Management’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Vanguard Capital Management's ADRX Position: Q3 2026 in Review
Vanguard Capital Management opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 43,331 shares worth $864K. The stake represents ﹤0.01% of the portfolio and ranks #3598 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Vanguard Capital Management held 43,331 shares of ADARx Pharmaceuticals worth $864K as of Q3 2026.
- ADARx Pharmaceuticals was a new Vanguard Capital Management position in Q3 2026.
- ADARx Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3598 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.